The concentration of SP-D is increased in the serum of COPD, IPF, and CF patients, increased in the lungs of asthmatics after allergen challenge, and decreased in the lungs of smokers [31], [32], [33], [34], [35], [36]. This evidence concerns the gene SFTPD and cystic fibrosis.